Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical Ketorolac with Bevacizumab for Diabetic Macular Edema
NCT04119921Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Jan 2018
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of ketorolac in diabetic macular edema (DME), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: Best-Corrected Visual Acuity at 12 weeks. Started Jan 2018; status: completed.
02
Drugs
ketorolac
03
Conditions
diabetic macular edema (DME)
Beyond the preview
Go deeper on NCT04119921.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04119921.